Helix BioPharma Corp. announced a private placement financing of 16,655,557 common shares at a price of CAD 0.18 per common share for proceeds of CAD 2,998,000 on August 15, 2023. The common shares issued pursuant are subject to a statutory hold period of four months and one day ending on December 16, 2023, in accordance with applicable securities law.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.205 CAD | -2.38% | -2.38% | -2.38% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.38% | 34.43M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- HBP Stock
- News Helix BioPharma Corp.
- Helix BioPharma Corp. announced that it expects to receive CAD 2.998 million in funding